Papillary fibroelastoma of the pulmonary valve--a systematic review

Fayaz A Hakim1, Madan Raj Aryal, Anil Pandit

  • 1Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Scottsdale, Arizona.

Insights

Pulmonary valve papillary fibroelastomas (PVPFE) are rare benign tumors. This review details their demographics, presentation, and management, highlighting potential complications like obstruction and embolism.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Oncology

Background:

  • Valvular papillary fibroelastomas are rare cardiac tumors.
  • The pulmonary valve is an uncommon site for these tumors.
  • Increased use of imaging has led to more frequent diagnoses.

Purpose of the Study:

  • To systematically review demographic characteristics of pulmonary valve papillary fibroelastomas (PVPFE).
  • To outline the clinical presentation, management strategies, and outcomes for PVPFE.
  • To address the rarity and potential complications of this benign pulmonary valve tumor.

Main Methods:

  • Systematic literature review.
  • Analysis of demographic data.
  • Evaluation of clinical presentations and management outcomes.

Main Results:

  • Pulmonary valve papillary fibroelastomas are infrequently diagnosed.
  • Shortness of breath is a common symptom in symptomatic patients.
  • Embolic events and right ventricular outflow tract obstruction are significant complications.

Conclusions:

  • Pulmonary valve papillary fibroelastomas require careful consideration due to potential serious complications.
  • Early recognition and appropriate management are crucial for favorable outcomes.
  • Further research is needed to fully understand the long-term prognosis of PVPFE.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.1K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
911
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
86
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K